Search Grant Opportunities

Exploratory Grants in Cancer Control (R21 Clinical Trial Optional)

ID: PA-25-253 • Type: Posted
Opportunity Assistant

Hello! Please let me know your questions about this opportunity. I will answer based on the available opportunity documents.

Sign in to upload a capability statement or catalogue for your company

Popular Questions:
Generate a draft:
Loading

Description

This funding opportunity announcement (FOA) encourages the submission of exploratory/developmental research grant (R21) applications that focus on different aspects of cancer control by modifying behavior, screening, and understanding etiologic factors contributing to the development of cancer, and developing ways to control cancer. The overarching goal is to provide support to promote the early and conceptual stages of research efforts on novel scientific ideas that have the potential to substantially advance population-based cancer research, such as the development of novel techniques, agents, methodologies, models, or applications that could have a major impact on a field of cancer research (epidemiologic, biomedical, behavioral, health care delivery or clinical).
Background
The Exploratory Grants in Cancer Control (R21 Clinical Trial Optional) is a funding opportunity announced by the National Cancer Institute (NCI), part of the National Institutes of Health (NIH). The purpose of this grant is to support exploratory and developmental research that focuses on various aspects of cancer control, including behavior modification, screening, and understanding factors contributing to cancer development.

The overarching goal is to advance population-based cancer research through innovative scientific ideas and methodologies that can significantly impact cancer research fields such as epidemiology, biomedical science, behavioral science, health care delivery, and clinical practice.

Grant Details
The R21 grant supports projects that can be completed within a two-year period. It encourages the submission of applications that explore novel techniques, agents, methodologies, models, or applications with the potential to advance cancer control. Specific areas of interest include:
- Development and validation of methods in surveillance, epidemiology, health care delivery, and behavioral sciences.
- Identification of modifiable risk factors associated with cancer prevention and treatment outcomes.
- Clinical and translational science aimed at reducing cancer risk and enhancing quality of life for survivors.
- Behavioral research targeting psychosocial factors across the cancer continuum.
- Health care delivery research focusing on improving patient-centered care and outcomes.
- Surveillance research aimed at developing analytical tools for population-based cancer statistics.

Eligibility Requirements
Eligible applicants include higher education institutions (public or private), nonprofits (with or without 501(c)(3) status), for-profit organizations (including small businesses), local governments, state governments, tribal governments (both federally recognized and others), federal agencies, foreign organizations, and faith-based organizations. Individuals from diverse backgrounds are encouraged to apply.

Period of Performance
The maximum project period for this grant is two years.

Grant Value
The combined budget for direct costs over the two-year project period may not exceed $275,000. No more than $200,000 may be requested in a single year.

Overview

Category of Funding
Education
Health
Funding Instruments
Grant
Grant Category
Discretionary
Cost Sharing / Matching Requirement
False
Source
On 11/12/24 the National Institutes of Health posted grant opportunity PA-25-253 for Exploratory Grants in Cancer Control (R21 Clinical Trial Optional). The grant will be issued under grant program 93.393 Cancer Cause and Prevention Research.

Timing

Posted Date
Nov. 12, 2024, 12:00 a.m. EST
Closing Date
Sept. 7, 2028, 12:00 a.m. EDT Due in 852 Days
Last Updated
Nov. 12, 2024, 10:58 a.m. EST
Version
1
Archive Date
Oct. 13, 2028

Eligibility

Eligible Applicants
Nonprofits having a 501(c)(3) status with the IRS, other than institutions of higher education
Public and State controlled institutions of higher education
Others (see text field entitled "Additional Information on Eligibility" for clarification)
For profit organizations other than small businesses
Special district governments
City or township governments
County governments
Private institutions of higher education
Small businesses
Independent school districts
State governments
Public housing authorities/Indian housing authorities
Nonprofits that do not have a 501(c)(3) status with the IRS, other than institutions of higher education
Native American tribal organizations (other than Federally recognized tribal governments)
Native American tribal governments (Federally recognized)
Additional Info
Other Eligible Applicants include the following: Alaska Native and Native Hawaiian Serving Institutions; Asian American Native American Pacific Islander Serving Institutions (AANAPISISs); Eligible Agencies of the Federal Government; Faith-based or Community-based Organizations; Hispanic-serving Institutions; Historically Black Colleges and Universities (HBCUs); Indian/Native American Tribal Governments (Other than Federally Recognized); Non-domestic (non-U.S.) Entities (Foreign Organizations); Regional Organizations; Tribally Controlled Colleges and Universities (TCCUs) ; U.S. Territory or Possession.

Contacts

Contact
National Institutes of Health
Contact Email
Email Description
See Section VII. Agency Contacts within the full opportunity announcement for all other inquires.
Contact Phone
(301) 402-2541
Additional Information
https://grants.nih.gov/grants/guide/pa-files/PA-25-253.html

Documents

Posted documents for PA-25-253

Opportunity Assistant


AI Analysis

AI Generate

Potential Applicants and Partners

Awardees that have recently won grants similar to PA-25-253

Incumbent or Similar Grants

Grants similar to PA-25-253

Similar Active Opportunities

Open grant opportunities similar to PA-25-253

Experts for Exploratory Grants in Cancer Control (R21 Clinical Trial Optional)

Recommended subject matter experts available for hire